Scholarlink

Purpose of review <p>Hepatocellular carcinoma (HCC) candidates rely on expanded donor utilization to maintain timely access to liver transplantation. Donation after circulatory death (DCD) allografts represent an important resource, but early experience raised concerns regarding inferior graft and patient outcomes compared with donation after brain death (DBD) donors. This review summarizes contemporary outcomes of DCD liver transplantation in HCC recipients and highlights the evolving role of advanced perfusion technologies in optimizing DCD outcomes.</p> Recent findings <p>Recent multicenter and meta-analytic data demonstrate comparable overall survival, graft survival, and recurrence-free survival between DCD and DBD grafts in appropriately selected HCC recipients. Advanced preservation strategies—including normothermic machine perfusion (NMP) and normothermic regional perfusion (NRP)—have improved DCD graft utilization and reduced ischemia-reperfusion injury and biliary complications. Emerging approaches such as hypothermic oxygenated machine perfusion (HOPE) and ischemia-free liver transplantation (IFLT) may further optimize outcomes and potentially reduce HCC recurrence.</p> Summary <p>Modern DCD liver transplantation is a safe and effective option for HCC recipients, and machine perfusion has been central to improving outcomes and expanding transplant access.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Donation After Circulatory Death Donor Liver Transplantation for Hepatocellular Carcinoma in the United States

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月9日

查看全文
  • Michie A. Adjei,
  • Steven A. Wisel

摘要

Purpose of review

Hepatocellular carcinoma (HCC) candidates rely on expanded donor utilization to maintain timely access to liver transplantation. Donation after circulatory death (DCD) allografts represent an important resource, but early experience raised concerns regarding inferior graft and patient outcomes compared with donation after brain death (DBD) donors. This review summarizes contemporary outcomes of DCD liver transplantation in HCC recipients and highlights the evolving role of advanced perfusion technologies in optimizing DCD outcomes.

Recent findings

Recent multicenter and meta-analytic data demonstrate comparable overall survival, graft survival, and recurrence-free survival between DCD and DBD grafts in appropriately selected HCC recipients. Advanced preservation strategies—including normothermic machine perfusion (NMP) and normothermic regional perfusion (NRP)—have improved DCD graft utilization and reduced ischemia-reperfusion injury and biliary complications. Emerging approaches such as hypothermic oxygenated machine perfusion (HOPE) and ischemia-free liver transplantation (IFLT) may further optimize outcomes and potentially reduce HCC recurrence.

Summary

Modern DCD liver transplantation is a safe and effective option for HCC recipients, and machine perfusion has been central to improving outcomes and expanding transplant access.